TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.100
+0.030 (1.45%)
Apr 28, 2026, 4:00 PM EDT - Market closed
TherapeuticsMD Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for TherapeuticsMD.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for TherapeuticsMD.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $5 | Hold | Reiterates | $5 | +138.10% | Aug 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $5 | Hold | Initiates | $5 | +138.10% | Jan 11, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $1 | Hold | Reiterates | $1 | -52.38% | Jul 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $10 | Strong Buy → Hold | Downgrades | $10 | +376.19% | Jun 7, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $250 → $50 | Buy → Hold | Downgrades | $250 → $50 | +2,280.95% | May 6, 2022 |
Financial Forecast
Revenue This Year
n/a
from 3.02M
Revenue Next Year
n/a
EPS This Year
n/a
from -0.05
EPS Next Year
n/a
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.